CClinicalTrials.gg
CompletedNCT04941560Updated Mar 21, 2023

Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases

An observational study in Coronary Artery Disease, sponsored by China National Center for Cardiovascular Diseases. Completed at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-21.

Sponsored by China National Center for Cardiovascular Diseases · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
460
Ages
18 Years and older
Sex
All
01

Study summary

The purposes of this study are 1) to explore the association between multi-dimension facial characteristics and the increased risk of coronary artery diseases (CAD); 2) to evaluate the diagnostic efficacy of multi-dimension appearance factors for coronary artery diseases.

Read the detailed description

Previous study demonstrated the feasibility of using deep learning to detect coronary artery disease based on facial photos. However, several limitations made the algorithm hard to be utilized in clinical practice, including low specificity and lack of external validation. Adding multi-dimension facial characteristics may further increase the algorithm effect.

Thus, the investigators designed a single-center, cross-sectional study to explore the association between multi-dimension facial characteristics and CAD and to evaluate the predictive efficacy of multi-dimension appearance factors for CAD. The investigators will recruit patients undergoing coronary angiography or coronary computer tomography angiography. Patients' baseline information and multi-dimension facial images will be collected. The investigators will train and validate a deep learning algorithm based on multi-dimension facial photos.

02

Conditions studied

  • Coronary Artery Disease

Keywords

  • Artificial intelligence
  • Facial characteristics
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's enrollment of 460 is above the median of 336 across 1,947 observational studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

China National Center for Cardiovascular Diseases is the lead sponsor of 256 studies on the registry; 134 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients who undergo coronary angiography or coronary computer tomography angiography from both resident patients and outpatient.

Inclusion criteria

  • Undergoing coronary angiography or coronary computer tomography angiography
  • Written informed consent

Exclusion criteria

Exclusion Criteria:

  • Prior percutaneous coronary intervention (PCI)
  • Prior coronary artery bypass graft (CABG)
  • Screening coronary artery disease before treating other heart diseases
  • Without blood biochemistry outcome
  • With artificially facial alteration (i.e. cosmetic surgery, facial trauma or make-up)
  • Other situations which make patients fail to be photographed
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
460 participants (actual)
Patient registry
No

Groups and cohorts

  • Algorithm training and test group

    Patients undergoing coronary angiography or coronary computer tomography angiography will be enrolled. Patients data will be used to training and validate the algorithm for CAD detection based on facial photos.

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Area under receiver operating curve (AUC)

    Area under receiver operating curve of algorithm assessed in test group

    Time frame: At the end of enrollment (1 mouth)

Secondary outcomes

  1. Sensitivity of algorithm

    Sensitivity of algorithm assessed in test group

    Time frame: At the end of enrollment (1 mouth)

  2. Specificity of algorithm

    Specificity of algorithm assessed in test group

    Time frame: At the end of enrollment (1 mouth)

  3. Positive predictive value (PPV)

    PPV of algorithm assessed in test group

    Time frame: At the end of enrollment (1 mouth)

  4. Negative predictive value (NPV)

    NPV of algorithm assessed in test group

    Time frame: At the end of enrollment (1 mouth)

  5. Diagnostic accuracy rate

    Diagnostic accuracy rate of algorithm assessed in test group

    Time frame: At the end of enrollment (1 mouth)

07

Study locations

1 site
  • Fuwai hospital
    Beijing, Beijing 100032, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04941560
Lead sponsor
China National Center for Cardiovascular Diseases
Responsible party
Sponsor
First posted
Jun 28, 2021
Start date
Sep 6, 2021
Primary completion
Feb 10, 2023
Completion
Feb 10, 2023
Last update
Mar 21, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion